Lynch Associatesin Lowers stake in Walgreens Boots Alliance Inc (WBA)

Walgreens Boots Alliance Inc (WBA) : Lynch Associatesin reduced its stake in Walgreens Boots Alliance Inc by 0.97% during the most recent quarter end. The investment management company now holds a total of 45,102 shares of Walgreens Boots Alliance Inc which is valued at $3,631,162 after selling 440 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on Oct 4, 2016.Walgreens Boots Alliance Inc makes up approximately 1.61% of Lynch Associatesin’s portfolio.

Other Hedge Funds, Including , Washington Trust Bank reduced its stake in WBA by selling 75 shares or 0.92% in the most recent quarter. The Hedge Fund company now holds 8,048 shares of WBA which is valued at $647,944. Walgreens Boots Alliance Inc makes up approx 0.16% of Washington Trust Bank’s portfolio.Lvm Capital Management Ltdmi reduced its stake in WBA by selling 31 shares or 0.92% in the most recent quarter. The Hedge Fund company now holds 3,350 shares of WBA which is valued at $269,709. Walgreens Boots Alliance Inc makes up approx 0.09% of Lvm Capital Management Ltdmi’s portfolio.Bath Savings Trust Co reduced its stake in WBA by selling 470 shares or 0.85% in the most recent quarter. The Hedge Fund company now holds 54,640 shares of WBA which is valued at $4,399,066. Walgreens Boots Alliance Inc makes up approx 1.39% of Bath Savings Trust Co’s portfolio.

Walgreens Boots Alliance Inc closed down -0.14 points or -0.17% at $80.24 with 31,11,612 shares getting traded on Tuesday. Post opening the session at $80.85, the shares hit an intraday low of $80.03 and an intraday high of $81.491 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.

Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Company shares were Reiterated by Deutsche Bank on Aug 30, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $93 .Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .

Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.

Leave a Reply

Walgreens Boots Alliance Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Walgreens Boots Alliance Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.